SNPHF OTC
Santen Pharmaceutical Co., Ltd.
1W: +1.0%
1M: +0.0%
3M: +0.0%
YTD: +37.2%
1Y: +14.0%
3Y: +44.7%
5Y: -3.3%
$13.05
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$43.8B
-28.2% ▼
5Y CAGR: +2.4%
Capital Expenditures
$6.9B
-3.4% ▼
5Y CAGR: -22.0%
Free Cash Flow
$36.9B
-32.0% ▼
5Y CAGR: +19.7%
Dividends Paid
$12.7B
-5.0% ▼
Buybacks
$33.0B
+12.9% ▲
Net Change in Cash
-$17.7B
-119.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $27.2B | -$15.0B | $26.6B | $36.3B | $37.6B |
| Depreciation & Amort. | $17.1B | $17.2B | $18.2B | $17.9B | $18.5B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $4.7B | -$5.1B | $14.2B | $10.2B | -$12.9B |
| Other Non-Cash Items | -$2.9B | $39.9B | $13.7B | -$3.5B | $573M |
| Operating Cash Flow | $46.0B | $37.1B | $72.6B | $60.9B | $43.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$35.8B | -$24.6B | -$9.3B | -$6.7B | -$14.4B |
| Acquisitions (Net) | -$3.0B | -$3.5B | -$207M | $0 | $0 |
| Investment Purchases | -$1.1B | -$589M | -$301M | $0 | -$213M |
| Investment Sales | $3.9B | $2.1B | $4.1B | $0 | $576M |
| Other Investing | $838M | -$279M | -$445M | -$1.6B | $938M |
| Investing Cash Flow | -$35.2B | -$26.8B | -$6.1B | -$8.2B | -$13.1B |
| — Financing Activities — | |||||
| Net Debt Issuance | $20.5B | $4.4B | -$2.1B | -$3.3B | $0 |
| Stock Repurchased | -$12M | -$26.0B | -$17.0B | -$37.9B | -$33.0B |
| Dividends Paid | -$12.0B | -$12.6B | -$11.9B | -$12.1B | -$12.7B |
| Other Financing | -$2.9B | -$3.0B | -$3.1B | $0 | -$3.9B |
| Financing Cash Flow | $5.6B | -$37.2B | -$34.0B | -$53.3B | -$49.7B |
| Net Change in Cash | $20.1B | -$25.1B | $36.7B | $93.0B | -$17.7B |
| Cash End of Period | $83.0B | $57.9B | $94.6B | $93.0B | $81.4B |
| Free Cash Flow | $10.2B | $12.6B | $62.0B | $54.3B | $36.9B |